VivAer® represents a significant breakthrough in treating Nasal Airway Obstruction (NAO), a condition that affects millions and often goes untreated or is poorly managed. Utilizing patented, temperature-controlled radiofrequency (RF) energy, VivAer gently remodels nasal tissue without cutting or removing it. The treatment specifically targets the internal nasal valve, the narrowest part of the nasal passage and a common source of airflow resistance. Its minimally invasive, non-surgical approach is designed to be performed in an office setting, eliminating the need for general anesthesia and offering patients a convenient, low-risk alternative to traditional nasal surgeries.

VivAer® is intended for patients who suffer from chronic nasal congestion or difficulty breathing due to structural blockage that isn't improved by medications. During a quick, outpatient procedure typically lasting less than 20 minutes, a specialized wand delivers RF energy to reshape the nasal tissues, expanding the airway and improving airflow. Most patients resume normal activities the same day, and many report noticeable improvements in nasal breathing almost immediately. Over time, the treated tissues stabilize, providing durable symptom relief with minimal discomfort and a low rate of complications.

The long-term data from VivAer’s third clinical study, showing sustained improvements over three years, underscores the treatment’s safety, durability, and effectiveness. As an FDA-cleared option with proven outcomes, VivAer fills a critical gap for patients with NAO who lack effective, long-lasting, non-surgical treatments. Its continued validation in peer-reviewed research makes it a compelling choice for ENT specialists and primary care providers seeking to enhance their patients’ quality of life. VivAer exemplifies how innovation can lead to better patient care—offering a reliable, minimally invasive solution to a common yet often underdiagnosed condition.

MedTech Spectrum's Summary

Innovative Technology: VivAer® uses temperature-controlled radiofrequency energy to gently remodel nasal tissue, offering a non-surgical, in-office solution for nasal airway obstruction.

Effective and Convenient: The quick outpatient procedure provides long-lasting relief from nasal congestion with minimal downtime, allowing patients to resume daily activities the same day.

Proven Long-Term Results: A third peer-reviewed study with three-year follow-up confirms VivAer’s safety, durability, and sustained improvement in nasal breathing, reinforcing its value as a reliable treatment option.